Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| NATIONAL HEALTH INVESTORS INCNHI · Entity 4125 | Director · CEO and President | June 05, 2026 | June 05, 2026 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
NATIONAL HEALTH INVESTORS INC
Report date June 05, 2026 · Filed June 05, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 133,316 |
Reported balance
After 2026-06-05 transaction · row 1
1 source rowRow 1 · 2026-06-05 · Purchase · Acquired 1,500 · Balance 133,316 |
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| February 22, 2017 Filed Feb 24, 2017 22:52 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | GrantStock Options (Right to Buy) 2-22-19 exp 2-22-22 · Derivative | 33,334 | $74.78 Strike: $74.78 | $2,492,716.52 |
DisclosureSEC source: 0001127602-17-008280 · form4.xml · derivative · entry 4 Mendelsohn D. Eric · CIK 0001410716 · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,334 Underlying: Common Stock · 33,334 shares Expires 2022-02-22 Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 22:52 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | GrantStock Options (Right to Buy) 2-22-18 Exp 2-22-22 · Derivative | 33,333 | $74.78 Strike: $74.78 | $2,492,641.74 |
DisclosureSEC source: 0001127602-17-008280 · form4.xml · derivative · entry 3 Mendelsohn D. Eric · CIK 0001410716 · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Underlying: Common Stock · 33,333 shares Expires 2022-02-22 Read SEC document |
| February 22, 2017 Filed Feb 24, 2017 22:52 UTC | NATIONAL HEALTH INVESTORS INC NHI · Entity 4125 | GrantStock Options (Right to Buy) - 2-22-17 exp 2-22-22 · Derivative | 33,333 | $74.78 Strike: $74.78 | $2,492,641.74 |
DisclosureSEC source: 0001127602-17-008280 · form4.xml · derivative · entry 2 Mendelsohn D. Eric · CIK 0001410716 · CEO and President 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,333 Underlying: Common Stock · 33,333 shares Expires 2022-02-22 Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.